Northway Biotech Launches Full-Service Viral Clearance Studies, Delivering Results Faster Than Industry Standards

With six newly created and operational identical BSL-2 laboratories, the Northway Biotech Biological CDMO can run VCS programs for up to six customers simultaneously, significantly easing the current bottlenecks of the Northway Biotech market, a biopharmaceutical contract development and manufacturing organization (CDMO), today announced the expansion of its supply of gene and protein-based therapy services with the incorporation of viral purifi…

Northway Biotech Launches Full-Service Viral Clearance Studies, Delivering Results Faster Than Industry Standards – EastMud

VILNIUS, LT, May 5, 2025 – (ACN Newswire via SeaPRwire.com) –  Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), today announced the expansion of its protein-based and gene therapy service offerings with the addition of Viral Clearance Studies (VCS) capabilities. This strategic growth follows the opening of Northway Biotech’s new Gene Therapy Center with dedicated cGMP facilities for virus-related …

Northway Biotech Launches Full-Service Viral Clearance Studies, Delivering Results Faster Than Industry Standards

With six newly established, identical BSL-2 laboratories now operational, biologics CDMO Northway Biotech can conduct VCS programs for up to six clients simultaneously, significantly alleviating current market bottlenecks VILNIUS, Lithuania, May 5, 2025 (Ecnetnews.com) – Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), today announced the expansion of its protein-based and gene therapy service of…

Northway Biotech Launches Full-Service Viral Clearance Studies, Delivering Results Faster Than Industry Standards - European Business & Finance Magazine

With six newly established, identical BSL-2 laboratories now operational, biologics CDMO Northway Biotech can conduct VCS programs for up to six clients